Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.37 |
| ▸ | PSMB2 | P49721 | 2/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP14 | P50281 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1402906 | 0.89 | KMT2A (0.60) | MEN1KMT2ATP53MAPTHPGD | |
| SCHEMBL1402756 | 0.84 | MMP2 (0.39) | MEN1KMT2ATP53MAPTHPGD | |
| SCHEMBL21264339 | 0.80 | ALDH1A1 (0.80) | MEN1KMT2ATP53MAPTHPGD | |
| SCHEMBL28405250 | 0.79 | TDP1 (0.50) | KMT2AKDM4EMMP2MMP3MMP9 | |
| SCHEMBL2734738 | 0.79 | DRD2 (0.40) | MAPTTSHRALDH1A1KDM4EMMP2 | |
| SCHEMBL1402783 | 0.79 | FFAR4 (0.38) | MEN1KMT2ATP53MAPTHPGD | |
| SCHEMBL12301079 | 0.79 | HIF1A (0.55) | MEN1KMT2ATP53MAPTHPGD | |
| SCHEMBL1402613 | 0.76 | LTA4H (0.44) | HPGDPSMB1PSMB5PSMB2HRH3 | |
| SCHEMBL21409497 | 0.76 | MMP2 (0.35) | MEN1KMT2ATP53MAPTHPGD | |
| SCHEMBL11849761 | 0.76 | LTA4H (0.45) | CYP1A2MAOBGRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114986-A1 | CURABLE COMPOSITION FOR MECHANICAL FOAMING AND METHOD FOR MANUFACTURING FOAM OF THE SAME | THREE BOND CO LTD (JP) | 2025-04-10 | — | — | US | disclosed |
| US-20230340330-A1 | COMPOSITION FOR COLOR CONVERSION FILM, COLOR CONVERSION FILM, METHOD FOR MANUFACTURING COLOR CONVERSION FILM, BACKLIGHT UNIT, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20220355517-A1 | CURABLE COMPOSITION FOR MECHANICAL FOAMING AND METHOD FOR MANUFACTURING FOAM OF THE SAME | THREEBOND CO., LTD. (JP) | 2022-11-10 | — | — | US | disclosed |
| US-11155669-B2 | Curable resin composition, cured product thereof, and bonded body bonded by cured product | THREEBOND CO., LTD. (JP) | 2021-10-26 | — | — | US | disclosed |
| EP-3885399-A1 | CURABLE COMPOSITION FOR MECHANICAL FOAMING, AND METHOD FOR MANUFACTURING FOAM OF SAME | ThreeBond Co., Ltd. (JP) | 2021-09-29 | — | — | EP | disclosed |
| CN-109790265-B | Curable resin composition, cured product thereof, and bonded body bonded with the cured product | 三键有限公司 | 2021-08-17 | — | — | CN | disclosed |
| US-20190211132-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT THEREOF, AND BONDED BODY BONDED WITH CURED PRODUCT THEREOF | THREEBOND CO., LTD. (JP) | 2019-07-11 | — | — | US | disclosed |
| CN-101687979-B | Resin composition | AJINOMOTO CO.,INC. (JP) | 2016-03-02 | — | — | CN | disclosed |
| EP-2698393-B1 | Resin composition | AJINOMOTO KK (JP) | 2015-08-19 | — | — | EP | disclosed |
| US-9018321-B2 | Resin composition | AJINOMOTO CO., INC. (JP) | 2015-04-28 | — | — | US | disclosed |
| CN-104334601-A | Curing agent for anionic curable compound, curable composition, cured product, novel imidazole compound, and use thereof | NIPPON SYNTHETIC CHEM IND | 2015-02-04 | — | — | CN | disclosed |
| EP-2698393-A1 | Resin composition | Ajinomoto Co., Inc. (JP) | 2014-02-19 | — | — | EP | disclosed |
| EP-2174969-A1 | RESIN COMPOSITION | Ajinomoto Co., Inc. (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20090030158-A1 | RESIN COMPOSITION | AJINOMOTO CO., INC (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030158-A1 | RESIN COMPOSITION | PPA1, PTGER1, TAF5 | MEN1 3932/4885KMT2A 2433/4885TP53 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.